Table 1.
Characteristics of the study participants.
| Control Group (n = 10) | Patients with PE (n = 11) | |
|---|---|---|
| Age (years) | 28 ± 2 | 29 ± 2 |
| Gestational age (weeks) | 39.0 ± 0.4 | 39.0 ± 0.5 |
| Systolic BP (mm Hg) | 112 ± 3 | 157 ± 5 * |
| Diastolic BP (mm Hg) | 72 ± 2 | 94 ± 2 * |
| Protein excretion (g per 24 h) | n/d | 2.12 ± 0.46 * |
| Plasma MBG (nmol/L) | 0.47 ± 0.10 | 1.6 ±0.5 * |
| Placental MBG (pmol/g) | 0.04 ± 0.01 | 0.49 ± 0.11 * |
| Erythrocyte Na/K-ATPase (µmol Pi/mL/h) | 2.7± 0.2 | 1.5 ± 0.2 * |
Means ± SEM. By two-tailed t-test: * p < 0.01 vs. control group. Control group, subjects with normal pregnancy; PE, patients with preeclampsia; BP, blood pressure; MBG, marinobufagenin.